Go to main content

diaTribe Musings LIVE at ADA 2024 in Orlando


Bridging Technology and Therapies to Improve Diabetes Outcomes: 
Integrating Innovative Solutions for Optimizing Care

Thursday, June 20, 2024
5:00-7:30pm EDT

The Gaylord Palms Resort, Emerald Bay Plaza
6000 West Osceola Parkway
Kissimmee, Florida 34746

Kick off the ADA Scientific Sessions in sunny Orlando, Florida with your colleagues and other major diabetes influencers at diaTribe Musings at ADA 2024.  Following a festive reception with food (and your favorite beverage) you’ll join an outstanding expert panel discussion with leaders from industry and research (see below) led by Dr. Alan Moses

Alan and the panel will explore how the advances in technology and therapies have and continue to facilitate the development of innovative solutions to improve care. The panelists will also focus on how CGM, time in range, and automated insulin delivery systems improve the implementation of therapies. 

Space is limited, so reserve your spot now, with discounted early-bird pricing through June 6, and deeply discounted tickets for clinicians, researchers and non-profit advocates.

Register Now!


Anila Bindal

Anila Bindal, MD
Associate Medical Director, Abbott Diabetes Care Business

Dr. Anila Bindal is Associate Medical Director for Abbott’s diabetes care business in the U.S.  As an endocrinologist, Dr. Bindal understands the challenges people living with diabetes face. For more than a decade, she’s dedicated her time to making diabetes care management easier while also sharing how food and movement can be a form of medicine.  At Abbott, Dr. Bindal’s focus is on diabetes education, clinical research, and advocating for greater access to life-changing diabetes technology, like Abbott’s FreeStyle Libre portfolio of continuous glucose monitors.  She continues her endocrinology practice part-time at Erie Health Center in Chicago to help the west side region’s medically underserved residents. Before joining Abbott, Dr. Bindal practiced in Chicago at Northwestern Medicine most recently, and Rush University Medical Center prior to that, where she co-founded its Cardiometabolic Center. She earned her medical degree from the Medical College of Wisconsin, following her bachelor’s from University of Michigan.


Photo of Professor Alice Cheng

Alice Y.Y. Cheng, MD, FRCPD
Associate Professor, University of Toronto | Endocrinologist, Trillium Health Partners

Dr. Alice Cheng is an Endocrinologist at Trillium Health Partners and Unity Health Toronto and an Associate Professor at the University of Toronto.  She has been involved with the development of the Diabetes Canada clinical practice guidelines since 2003 and served as Chair for the 2013 version.  She is serving as Chair of the Scientific Planning Committee for the 2023 and 2024 American Diabetes Association annual scientific meetings – the largest international diabetes conference.  In addition, she is an Associate Editor for the journal, Diabetes Care, and co-host of the podcast series “Diabetes Care On Air”.   In recognition of her contribution to the diabetes community, she has received the national Charles H. Best Award and the Gerald S. Wong Service Award from Diabetes Canada.  She is also the creator of The Med Ed Pledge – an initiative to increase Diversity & Inclusion in continuing medical education (www.theMedEdPledge.com) along with CMEX – a searchable database of health care professionals interested in contributing to medical education.


Photo of Dr. Thomas Grace

Thomas Grace, MD, CDCES, ABOM
Head of Advocacy and Clinical Outcomes, Dexcom

Dr. Thomas Grace is a family medicine physician and diabetologist. He is the director and clinician at the Blanchard Valley Diabetes Center in Findlay, Ohio. He completed his undergraduate studies at the University of Michigan before attending the American University of the Caribbean Medical School. Dr. Grace completed his family medicine residency at Beaumont Hospital in Detroit, Michigan. He has a passion for diabetes and education. His interest in diabetes stems from his personal journey with type 1 diabetes, diagnosed at the age of 3. He recently joined Dexcom as the Head of Advocacy and Clinical Outcomes, as he is interested in expanding access of CGMs to everyone with diabetes. He has several publications and currently is running a longitudinal real world study in his community using rtCGM.


Jennifer McVean

Jennifer McVean, MD
Senior Director of Global Medical Affairs, Medtronic

Dr. Jennifer McVean is a pediatric endocrinologist and Senior Director of Global Medical Affairs at Medtronic.  Prior to joining Medtronic in 2022, she was an Associate Professor of Pediatric Endocrinology at the University of Minnesota.  After completing her undergraduate work at Northwestern University, she attended medical school at the University of Minnesota Medical School.  Dr. McVean completed a pediatric residency at the University of Colorado and a pediatric endocrinology fellowship at the University of Wisconsin-Madison.  Her clinical and research interest is type 1 diabetes.  She envisioned and led the JDRF funded "Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes", CLVer trial.  Dr. McVean’s passion for type 1 diabetes stems from her own diagnosis at age 11.  


Photo of Dr. Laurel Messer

Laurel Messer, PhD, MPH, RN, CDCES
Senior Director of Medical Affairs, Tandem Diabetes Care

Dr. Laurel Messer is the Senior Director of Medical Affairs at Tandem Diabetes Care, leading clinical strategy and global evidence generation. Dr. Messer is also an Assistant Clinical Professor of Pediatrics at the Barbara Davis Center for Diabetes, University of Colorado School of Medicine. She has specialized in the care of youth and young adults with Type 1 Diabetes for 18 years as a clinical scientist, nurse, and Certified Diabetes Care and Education Specialist. In her academic role, she has served as a research investigator and clinical educator for diabetes technology trials including CGM, insulin pumps, and automated insulin delivery systems. Dr. Messer has authored over 80 publications related to diabetes, and lectures/teaches on diabetes technology at universities, hospitals, and national and international conferences. Dr. Messer also founded the PANTHERProgram (http://PANTHERprogram.org, “Diabetes Technology. Deciphered”) , a website for persons with diabetes and healthcare professionals who want to engage with diabetes technology. 



Alan Moses

Alan Moses, MD, FACP
Board Chair, The diaTribe Foundation | Past Chief Medical Officer, Joslin Diabetes Center and Novo Nordisk

Dr. Alan Moses is an independent consultant for the pharmaceutical and biotechnology sector. Trained in internal medicine and endocrinology, he spent the major part of his academic career at Harvard doing bench and clinical research and clinical care and rising to a position of Professor of Medicine. Dr. Moses co-founded and directed the Clinical Investigator Training Program at Beth Israel Deaconess-Harvard Medical School-MIT. From 1998 to 2004, Dr. Moses served as Senior Vice President and Chief Medical Officer of the Joslin Diabetes Center with specific responsibility for the Joslin Clinic. He joined Novo Nordisk in 2004. During his 14 years at Novo Nordisk, Dr. Moses served in multiple roles beginning as Associate Vice President of Medical Affairs in the US and rising to the position of Senior Vice President and Global Chief Medical Officer working in Copenhagen. Dr. Moses earned his MD from the Washington University School of Medicine in St. Louis, worked for three years at the National Institutes of Health, completed his clinical endocrine/diabetes training at Tufts New England Medical Center, and studied Health Care Strategy at Harvard Business School. He retired from Novo Nordisk in June 2018. He has been a member of the Board of Directors of The diatribe Foundation since September 2018.

Register Now!



Thank you to our sponsors for making this event possible
(sponsors in formation)

Gold Sponsors




Dexcom Green Logo




Tandem Diabetes Care Logo

Silver Sponsors